RNA Helicase DDX5 Maintains Cardiac Function by Regulating CamkIIδ Alternative Splicing.

IF 5.2 3区 工程技术 Q2 ENERGY & FUELS Energy & Fuels Pub Date : 2024-10-01 Epub Date: 2024-07-26 DOI:10.1161/CIRCULATIONAHA.123.064774
Kangni Jia, Haomai Cheng, Wenqi Ma, Lingfang Zhuang, Hao Li, Zhigang Li, Ziyang Wang, Hang Sun, Yuke Cui, Hang Zhang, Hongyang Xie, Lei Yi, Zhiyong Chen, Motoaki Sano, Keiichi Fukuda, Lin Lu, Jun Pu, Yan Zhang, Ling Gao, Ruiyan Zhang, Xiaoxiang Yan
{"title":"RNA Helicase DDX5 Maintains Cardiac Function by Regulating <i>CamkIIδ</i> Alternative Splicing.","authors":"Kangni Jia, Haomai Cheng, Wenqi Ma, Lingfang Zhuang, Hao Li, Zhigang Li, Ziyang Wang, Hang Sun, Yuke Cui, Hang Zhang, Hongyang Xie, Lei Yi, Zhiyong Chen, Motoaki Sano, Keiichi Fukuda, Lin Lu, Jun Pu, Yan Zhang, Ling Gao, Ruiyan Zhang, Xiaoxiang Yan","doi":"10.1161/CIRCULATIONAHA.123.064774","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) is a leading cause of morbidity and mortality worldwide. RNA-binding proteins are identified as regulators of cardiac disease; DDX5 (dead-box helicase 5) is a master regulator of many RNA processes, although its function in heart physiology remains unclear.</p><p><strong>Methods: </strong>We assessed DDX5 expression in human failing hearts and a mouse HF model. To study the function of DDX5 in heart, we engineered cardiomyocyte-specific <i>Ddx5</i> knockout mice. We overexpressed DDX5 in cardiomyocytes using adeno-associated virus serotype 9 and performed transverse aortic constriction to establish the murine HF model. The mechanisms underlined were subsequently investigated using immunoprecipitation-mass spectrometry, RNA-sequencing, alternative splicing analysis, and RNA immunoprecipitation sequencing.</p><p><strong>Results: </strong>We screened transcriptome databases of murine HF and human dilated cardiomyopathy samples and found that DDX5 was significantly downregulated in both. Cardiomyocyte-specific deletion of <i>Ddx5</i> resulted in HF with reduced cardiac function, an enlarged heart chamber, and increased fibrosis in mice. DDX5 overexpression improved cardiac function and protected against adverse cardiac remodeling in mice with transverse aortic constriction-induced HF. Furthermore, proteomics revealed that DDX5 is involved in RNA splicing in cardiomyocytes. We found that DDX5 regulated the aberrant splicing of Ca<sup>2+</sup>/calmodulin-dependent protein kinase IIδ (<i>CamkIIδ</i>), thus preventing the production of CaMKIIδA, which phosphorylates L-type calcium channel by serine residues of Cacna1c, leading to impaired Ca<sup>2+</sup> homeostasis. In line with this, we found increased intracellular Ca<sup>2+</sup> transients and increased sarcoplasmic reticulum Ca<sup>2+</sup> content in DDX5-depleted cardiomyocytes. Using adeno-associated virus serotype 9 knockdown of CaMKIIδA partially rescued the cardiac dysfunction and HF in <i>Ddx5</i> knockout mice.</p><p><strong>Conclusions: </strong>These findings reveal a role for DDX5 in maintaining calcium homeostasis and cardiac function by regulating alternative splicing in cardiomyocytes, identifying the DDX5 as a potential target for therapeutic intervention in HF.</p>","PeriodicalId":35,"journal":{"name":"Energy & Fuels","volume":null,"pages":null},"PeriodicalIF":5.2000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Energy & Fuels","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCULATIONAHA.123.064774","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENERGY & FUELS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Heart failure (HF) is a leading cause of morbidity and mortality worldwide. RNA-binding proteins are identified as regulators of cardiac disease; DDX5 (dead-box helicase 5) is a master regulator of many RNA processes, although its function in heart physiology remains unclear.

Methods: We assessed DDX5 expression in human failing hearts and a mouse HF model. To study the function of DDX5 in heart, we engineered cardiomyocyte-specific Ddx5 knockout mice. We overexpressed DDX5 in cardiomyocytes using adeno-associated virus serotype 9 and performed transverse aortic constriction to establish the murine HF model. The mechanisms underlined were subsequently investigated using immunoprecipitation-mass spectrometry, RNA-sequencing, alternative splicing analysis, and RNA immunoprecipitation sequencing.

Results: We screened transcriptome databases of murine HF and human dilated cardiomyopathy samples and found that DDX5 was significantly downregulated in both. Cardiomyocyte-specific deletion of Ddx5 resulted in HF with reduced cardiac function, an enlarged heart chamber, and increased fibrosis in mice. DDX5 overexpression improved cardiac function and protected against adverse cardiac remodeling in mice with transverse aortic constriction-induced HF. Furthermore, proteomics revealed that DDX5 is involved in RNA splicing in cardiomyocytes. We found that DDX5 regulated the aberrant splicing of Ca2+/calmodulin-dependent protein kinase IIδ (CamkIIδ), thus preventing the production of CaMKIIδA, which phosphorylates L-type calcium channel by serine residues of Cacna1c, leading to impaired Ca2+ homeostasis. In line with this, we found increased intracellular Ca2+ transients and increased sarcoplasmic reticulum Ca2+ content in DDX5-depleted cardiomyocytes. Using adeno-associated virus serotype 9 knockdown of CaMKIIδA partially rescued the cardiac dysfunction and HF in Ddx5 knockout mice.

Conclusions: These findings reveal a role for DDX5 in maintaining calcium homeostasis and cardiac function by regulating alternative splicing in cardiomyocytes, identifying the DDX5 as a potential target for therapeutic intervention in HF.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
RNA 螺旋酶 DDX5 通过调控 CamkIIδ 替代剪接维持心脏功能
背景:心力衰竭(HF)是全球发病率和死亡率的主要原因。RNA结合蛋白被认为是心脏疾病的调节因子;DDX5(死盒螺旋酶5)是许多RNA过程的主调节因子,但其在心脏生理中的功能仍不清楚:我们评估了 DDX5 在人类衰竭心脏和小鼠高频模型中的表达。为了研究 DDX5 在心脏中的功能,我们设计了心肌细胞特异性 Ddx5 基因敲除小鼠。我们利用 9 号血清型腺相关病毒在心肌细胞中过表达 DDX5,并进行横向主动脉收缩以建立小鼠高频模型。随后使用免疫沉淀质谱法、RNA测序法、替代剪接分析法和RNA免疫沉淀测序法对上述机制进行了研究:我们筛选了小鼠高频和人类扩张型心肌病样本的转录组数据库,发现DDX5在两者中均显著下调。心肌细胞特异性缺失 Ddx5 会导致小鼠患心功能减退、心腔扩大和纤维化加重的高房颤。过表达 DDX5 可改善横主动脉缩窄诱导的 HF 小鼠的心功能,并保护其免受不良心脏重塑的影响。此外,蛋白质组学发现 DDX5 参与了心肌细胞中的 RNA 剪接。我们发现 DDX5 可调节 Ca2+/calmodulin 依赖性蛋白激酶 IIδ (CamkIIδ)的异常剪接,从而阻止 CaMKIIδA 的产生,而 CaMKIIδA 可通过 Cacna1c 的丝氨酸残基使 L 型钙通道磷酸化,导致 Ca2+ 平衡受损。与此相应,我们发现在去除了 DDX5 的心肌细胞中,细胞内 Ca2+ 瞬时增加,肌浆网 Ca2+ 含量增加。利用腺相关病毒血清型 9 敲除 CaMKIIδA 可部分缓解 Ddx5 敲除小鼠的心功能障碍和高房颤:这些发现揭示了 DDX5 通过调节心肌细胞中的替代剪接在维持钙稳态和心脏功能中的作用,从而确定 DDX5 是治疗干预高房血症的潜在靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Energy & Fuels
Energy & Fuels 工程技术-工程:化工
CiteScore
9.20
自引率
13.20%
发文量
1101
审稿时长
2.1 months
期刊介绍: Energy & Fuels publishes reports of research in the technical area defined by the intersection of the disciplines of chemistry and chemical engineering and the application domain of non-nuclear energy and fuels. This includes research directed at the formation of, exploration for, and production of fossil fuels and biomass; the properties and structure or molecular composition of both raw fuels and refined products; the chemistry involved in the processing and utilization of fuels; fuel cells and their applications; and the analytical and instrumental techniques used in investigations of the foregoing areas.
期刊最新文献
A Tale of Two Maladies: Interplay of Mendelian Principles. Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome. Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines. Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1